DexCom Stock: Is Wall Street Bullish or Bearish?

DexCom, Inc. (DXCM), headquartered in San Diego, California, is a leading medical-device company that designs, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company’s market cap is around $23.2 billion. Shares of the medical device company have massively underperformed the broader market. Over the past 52 weeks, DXCM stock has declined 19.8%, while the broader S&P 500 Index ($SPX) has rallied 14.5%. Also, the stock is down 23 ...